Bioactive substance
US7667052B2 · kind B2 · utility
4Cited by
4References
29Claims
0Family size
Assignee
Inventors
- Yoshiharu Mizui
- Takashi Sakai
- Satoshi Yamamoto
- Keisuke Komeda
- Masanori Fujita
- Akifumi Okuda
- Kumiko Kishi
- Jun Niijima
- Mitsuo Nagai
- Kiyoshi Okamoto
- Masao Iwata
- Yoshihiko Kotake
- Toshimitsu Uenaka
- Naoki Asai
- Motoko Matsufuji
- Tomohiro Sameshima
- Naoto Kawamura
- Kazuyuki Dobashi
- Takashi Nakashima
- Masashi Yoshida
- Toshio Tsuchida
- Susumu Takeda
- Tomonari Yamada
- Koji Norihisa
- Takao Yamori
Key dates
| Filing date | Aug 30, 2005 |
| Grant date | Feb 23, 2010 |
| Priority date | — |
| Expiry date | Jan 12, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12P17/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a novel bioactive substance having an antitumor activity and a process for producing it, and a medical use thereof. Namely, it provides a 12-membered ring macrolide compound represented by the following formula obtained from the incubation solution of Streptomyces sp. Mer. 11107 or a variant thereof, a pharmacologically acceptable salt thereof or a hydrate of them, and a process for producing it.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.